KEB Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,300
| Closed | -$233K | – | 71 |
|
|
2024
Q1 | $233K | Hold |
4,300
| – | – | 0.08% | 63 |
|
|
2023
Q4 | $221K | Hold |
4,300
| – | – | 0.08% | 64 |
|
|
2023
Q3 | $250K | Hold |
4,300
| – | – | 0.1% | 52 |
|
|
2023
Q2 | $275K | Hold |
4,300
| – | – | 0.11% | 47 |
|
|
2023
Q1 | $298K | Hold |
4,300
| – | – | 0.13% | 44 |
|
|
2022
Q4 | $309K | Sell |
4,300
-24
| -0.6% | -$1.73K | 0.16% | 42 |
|
|
2022
Q3 | $307K | Buy |
4,324
+24
| +0.6% | +$1.7K | 0.2% | 37 |
|
|
2022
Q2 | $331K | Buy |
+4,300
| New | +$331K | 0.21% | 34 |
|
|
2022
Q1 | – | Sell |
-4,552
| Closed | -$284K | – | 45 |
|
|
2021
Q4 | $284K | Buy |
+4,552
| New | +$284K | 0.18% | 38 |
|